M1372 HCPCS Level II Code: Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%
M1372 is the authoritative medical code for Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%. This classification is used in medical billing and clinical recording to specify the clinical criteria for most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0% (HCPCS Level II M1372), ensuring healthcare documentation aligns with current federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Medicare Coverage & Payment
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Service not separately priced (pricing indicator 00)
- BETOS: Z2
- Effective: January 1, 2025
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Official Registry Overview & Definition
Nearest Codes in This Family
Official HCPCS Level II classifications closest to M1372 in its code family, with their registry titles.
- M1367 — Quality care for the treatment of ear, nose, and throat disorders mips value pathway
- M1368 — Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway
- M1369 — Quality care in mental health and substance use disorders mips value pathway
- M1370 — Rehabilitative support for musculoskeletal care mips value pathway
- M1371 — Most recent glycemic status assessment (hba1c or gmi) level < 7.0%
- M1373 — Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%
- M1374 — An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period
- M1375 — An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period
- M1376 — An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period
- M1377 — Recommended follow-up interval for repeat colonoscopy of 10 years documented in colonoscopy report and communicated with patient